Top compounds associated with response to DCXR


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.035 0.4
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.033 0.4
mRNA pac-1 GDSC1000 pan-cancer AAC -0.034 0.4
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.4
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.028 0.4
mRNA lapatinib FIMM pan-cancer AAC 0.17 0.4
mRNA QS11 GDSC1000 pan-cancer AAC 0.033 0.4
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA ML203 CTRPv2 pan-cancer AAC 0.037 0.4
Download CSV